Cargando…
Autoantibodies in Melanoma-Associated Retinopathy Recognize an Epitope Conserved Between TRPM1 and TRPM3
PURPOSE: Melanoma-associated retinopathy (MAR) is a paraneoplastic syndrome associated with malignant melanoma and the presence of anti-retinal autoantibodies, including autoantibodies against transient receptor potential melanopsin 1 (TRPM1), a cation channel expressed by both melanocytes and retin...
Autores principales: | Duvoisin, Robert M., Haley, Tammie L., Ren, Gaoying, Strycharska-Orczyk, Iwona, Bonaparte, James P., Morgans, Catherine W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455167/ https://www.ncbi.nlm.nih.gov/pubmed/28549093 http://dx.doi.org/10.1167/iovs.17-21443 |
Ejemplares similares
-
TRPM1 Autoantibodies in Melanoma Patients Without Self-Reported Visual Symptoms
por: Duvoisin, Robert M., et al.
Publicado: (2019) -
TRPM3 Expression in Mouse Retina
por: Brown, R. Lane, et al.
Publicado: (2015) -
Serum TRPM1 Autoantibodies from Melanoma Associated Retinopathy Patients Enter Retinal ON-Bipolar Cells and Attenuate the Electroretinogram in Mice
por: Xiong, Wei-Hong, et al.
Publicado: (2013) -
Identification and characterization of novel TRPM1 autoantibodies from serum of patients with melanoma-associated retinopathy
por: Varin, Juliette, et al.
Publicado: (2020) -
Correction: Identification and characterization of novel TRPM1 autoantibodies from serum of patients with melanoma-associated retinopathy
Publicado: (2020)